Evkeeza (evinacumab)

£12,780.00£14,780.00

Evkeeza (evinacumab) is an injectable medicine used together with other low-density lipoprotein (LDL)-lowering medicines in people aged 12 years and older with a type of high cholesterol called Homozygous Familial Hypercholesterolemia (HoFH).

DISEASE INDICATIONS

Hypercholesterolemia

MANUFACTURER

Regeneron Pharmaceuticals, Inc.

USAGE

Intravenous

MEDICINE APPROVED BY

  • Food and Drug Administration (FDA)

    PATIENTS HELPED

    • Over 1.2 million patients reached

    • More than 11,000 patients helped

    • 100% successful deliveries to 88 countries

This content has been reviewed by a Medical Doctor.
EVKEEZA (EVINACUMAB) Package

1 vial of 345 mg/2.3 mL (150 mg/mL), 1 vial of 1,200 mg/8 mL (150 mg/mL)

Reviews

There are no reviews yet.

Be the first to review “Evkeeza (evinacumab)”

Your email address will not be published. Required fields are marked *

Shopping Cart